Tumor‐Associated Lactic Acidosis and Early Death in Patients With Lymphoma
Cancer Medicine · 2025-04 · 14 (7)
DOI: 10.1002/cam4.70824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 28.03.2025. Verfasst von Bahaa Atamna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel. Hauptthemen laut MEDLINE: Acidosis, Lactic, Lymphoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cancer is characterized by accelerated glycolysis with enhanced glucose uptake and lactate production, a phenomenon termed Warburg effect (WE). We studied the incidence and clinical impact of Warburg‐driven lactic acidosis in lymphoma.
Methods
Patients admitted with newly diagnosed or relapsed/refractory lymphoma and documented lactate levels during the first week of admission were included. Patients with lactatemia were classified as secondary (with a recognizable cause for elevated lactate) or none (WE group).
Results
WE and secondary lactatemia were documented in 58 and 44 patients (15% and 12% of evaluable patients, respectively). Both WE and secondary lactatemia were associated with poor short‐term survival. WE at presentation correlated with tumor burden, with most patients having aggressive disease, advanced stage, and extranodal involvement. WE was associated with high rates of early death (26% and 43% at 30‐ and 60‐days, respectively). Higher lactate levels correlated with worse survival. Earlier initiation of chemotherapy was associated with a (nonsignificant) trend toward better outcomes, whereas steroid and/or thiamine therapy did not alter patient outcomes. Glucose administration was associated with worse survival.
Conclusion
WE‐driven lactatemia is associated with high tumor burden and increased short‐term mortality in lymphoma. Prompt initiation of anti‐lymphoma therapy may improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.
- Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Institute of Hematology, Meir Medical Center, Kfar-Saba, Israel.
ORCID-Profile: Alon Rozental, Gilad Itchaki, Ofir Wolach
Zitieren
APA
Atamna, B., Rozental, A., Haj Yahia, M., Itchaki, G., Gurion, R., Yeshurun, M., Raanani, P., & Wolach, O. (2025). Tumor‐Associated Lactic Acidosis and Early Death in Patients With Lymphoma. Cancer Medicine, 14(7). https://doi.org/10.1002/cam4.70824
Vancouver
Atamna B, Rozental A, Haj Yahia M, Itchaki G, Gurion R, Yeshurun M, et al. Tumor‐Associated Lactic Acidosis and Early Death in Patients With Lymphoma. Cancer Medicine. 2025;14(7). doi:10.1002/cam4.70824
BibTeX
@article{Atamna2025,
author = {Atamna, Bahaa and Rozental, Alon and Haj Yahia, Mohammad and Itchaki, Gilad and Gurion, Ronit and Yeshurun, Moshe and Raanani, Pia and Wolach, Ofir},
title = {Tumor‐Associated Lactic Acidosis and Early Death in Patients With Lymphoma},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {7},
doi = {10.1002/cam4.70824}
}
EUVIMED